Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (58)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sonmezer, M.
Right arrow Articles by Oktay, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sonmezer, M.
Right arrow Articles by Oktay, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction Update, Vol.10, No.3 pp.251-266, 2004
© European Society of Human Reproduction and Embryology 2004; all rights reserved

Fertility preservation in female patients

Murat Sonmezer1,2 and Kutluk Oktay2,3

1 Ankara University School of Medicine, Department of Obstetrics and Gynecology, Ankara, Turkey and 2 The Center for Reproductive Medicine and Infertility, Department of Obstetrics and Gynecology, Joan and Sanford I. Weill Medical College of Cornell University, 505 East 70th Street, HT-340, New York, NY 10021, USA 3 To whom correspondence should be addressed. e-mail: kuo9001{at}med.cornell.edu

In the USA alone, >650 000 women will be afflicted by cancer in 2003, and 8% of these cases will be aged <40 years. Due to improvements in cancer therapy, cure rates of both adult and childhood cancers increased significantly over the past three decades. However, long-term consequences of cancer therapy and impact on quality of life are now being recognized. One of the major sequelae of cytotoxic chemotherapy is gonadal failure. Cytotoxic chemotherapy and/or radiotherapy are not only used to treat malignant diseases, but also non-malignant systemic conditions. Upon reviewing the extent and mechanism of gonadal damage due to chemo-/radiotherapy, this article discusses indications and the wide range of methods of fertility preservation in a comprehensive manner. All current, emerging, experimental as well as controversial approaches are reviewed. A comprehensive algorithm to manage fertility preservation through an individualized approach is presented.

Key words: chemotherapy/fertility preservation/ovarian failure/radiotherapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
R. A. Anderson, A. Weddell, H. A. Spoudeas, C. Douglas, S. M. Shalet, G. Levitt, and W. H. B. Wallace
Do doctors discuss fertility issues before they treat young patients with cancer?
Hum. Reprod., July 9, 2008; (2008) den252v1.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Huser, I. Crha, P. Ventruba, R. Hudecek, J. Zakova, L. Smardova, Z. Kral, and J. Jarkovsky
Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients
Hum. Reprod., April 1, 2008; 23(4): 863 - 868.
[Abstract] [Full Text] [PDF]


Home page
Am Soc Clin Oncol Ed BookHome page
K. Oktay
Fertility Preservation Options for Young Women with Cancer
ASCO Educational Book, January 1, 2008; 2008(1): 43 - 47.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
O. Oktem and K. Oktay
A Novel Ovarian Xenografting Model to Characterize the Impact of Chemotherapy Agents on Human Primordial Follicle Reserve
Cancer Res., November 1, 2007; 67(21): 10159 - 10162.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
K. Oktay, M. Sonmezer, O. Oktem, K. Fox, G. Emons, and H. Bang
Absence of Conclusive Evidence for the Safety and Efficacy of Gonadotropin-Releasing Hormone Analogue Treatment in Protecting Against Chemotherapy-Induced Gonadal Injury
Oncologist, September 1, 2007; 12(9): 1055 - 1066.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. Oktay and O. Oktem
Regeneration of Oocytes After Chemotherapy: Connecting the Evidence From Mouse to Human
J. Clin. Oncol., August 1, 2007; 25(22): 3185 - 3187.
[Full Text] [PDF]


Home page
Hum ReprodHome page
R.A. Anderson, A.P.N. Themmen, A.A. -Qahtani, N.P. Groome, and D.A. Cameron
The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer
Hum. Reprod., October 1, 2006; 21(10): 2583 - 2592.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
J. Donnez, B. Martinez-Madrid, P. Jadoul, A. Van Langendonckt, D. Demylle, and M.-M. Dolmans
Ovarian tissue cryopreservation and transplantation: a review
Hum. Reprod. Update, September 1, 2006; 12(5): 519 - 535.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. Oktay, O. Oktem, A. Reh, and L. Vahdat
Measuring the Impact of Chemotherapy on Fertility in Women With Breast Cancer
J. Clin. Oncol., August 20, 2006; 24(24): 4044 - 4046.
[Full Text] [PDF]


Home page
JCOHome page
S. J. Lee, L. R. Schover, A. H. Partridge, P. Patrizio, W. H. Wallace, K. Hagerty, L. N. Beck, L. V. Brennan, and K. Oktay
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
J. Clin. Oncol., June 20, 2006; 24(18): 2917 - 2931.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Oktay
Spontaneous conceptions and live birth after heterotopic ovarian transplantation: is there a germline stem cell connection?
Hum. Reprod., June 1, 2006; 21(6): 1345 - 1348.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
M. Sonmezer and K. Oktay
Fertility preservation in young women undergoing breast cancer therapy.
Oncologist, May 1, 2006; 11(5): 422 - 434.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
M. T. Knobf
The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors.
Oncologist, February 1, 2006; 11(2): 96 - 110.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Bordes, J. Lornage, B. Demirci, M. Franck, B. Courbiere, J. F. Guerin, and B. Salle
Normal gestations and live births after orthotopic autograft of vitrified-warmed hemi-ovaries into ewes
Hum. Reprod., October 1, 2005; 20(10): 2745 - 2748.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. J. Goodwin, K. H. Oktay, and R. A. Lobo
Options for preservation of fertility in women.
N. Engl. J. Med., September 29, 2005; 353(13): 1418 - 1420.
[Full Text] [PDF]


Home page
NEJMHome page
S. J. Silber, K. M. Lenahan, D. J. Levine, J. A. Pineda, K. S. Gorman, M. J. Friez, E. C. Crawford, and R. G. Gosden
Ovarian Transplantation between Monozygotic Twins Discordant for Premature Ovarian Failure
N. Engl. J. Med., July 7, 2005; 353(1): 58 - 63.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S.-U. Chen, Y.-R. Lien, H.-F. Chen, L.-J. Chang, Y.-Y. Tsai, and Y.-S. Yang
Observational clinical follow-up of oocyte cryopreservation using a slow-freezing method with 1,2-propanediol plus sucrose followed by ICSI
Hum. Reprod., July 1, 2005; 20(7): 1975 - 1980.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
S. Oehninger
Strategies for Fertility Preservation in Female and Male Cancer Survivors
Reproductive Sciences, May 1, 2005; 12(4): 222 - 231.
[Abstract] [PDF]


Home page
JCOHome page
C. M. Duffy, S. M. Allen, and M. A. Clark
Discussions Regarding Reproductive Health for Young Women With Breast Cancer Undergoing Chemotherapy
J. Clin. Oncol., February 1, 2005; 23(4): 766 - 773.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
K. Lutchman Singh, M. Davies, and R. Chatterjee
Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing
Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.